U.S. federal judge has blocked key parts of Health Secretary Robert F. Kennedy Jr.’s effort to overhaul childhood vaccine policy, dealing a major setback to the Trump administration’s attempt to rewrite how vaccines are recommended in the United States. U.S. District Judge Brian Murphy in Boston sided with major medical groups—including the American Academy of Pediatrics—who argued that the administration’s changes were unlawfully implemented and would harm public health by weakening routine immunization guidance.
The ruling targets two core pillars of Kennedy’s agenda. First, the judge halted steps that would reduce or roll back the recommended childhood vaccine schedule. Second, the judge blocked Kennedy’s reconstitution of the Advisory Committee on Immunization Practices (ACIP), the influential panel that advises the CDC on which vaccines should be recommended and for whom. Seemingly, Kennedy had removed the committee’s prior expert members and replaced them with appointees critics described as largely unqualified, including figures associated with vaccine skepticism. The court’s order prevents those new appointees from serving and forced cancellation of an upcoming ACIP meeting.
Why ACIP matters is practical, not abstract. ACIP recommendations help shape not only clinical guidance but also insurance coverage and the standard vaccine schedules that pediatricians rely on. The plaintiffs argued that disrupting that process—especially by reshaping the panel and changing recommendations without the usual scientific and procedural safeguards—creates confusion for parents and providers and could lower vaccination rates. Kennedy’s changes announced earlier in 2026 included halting broad recommendations for several routine vaccines, contributing to the legal challenge and the judge’s decision to temporarily block the overhaul.
In his ruling, Judge Murphy emphasized the importance of established procedures and the scientific basis historically used to guide vaccine policy. The judge found legal flaws in how the changes were implemented and concluded that the reworked advisory structure could not legally proceed as the administration intended. The decision effectively pauses Kennedy’s vaccine rewrite while the case continues, keeping prior guidance in place for now.
The Trump administration is expected to appeal. The decision drew praise from public health experts and medical organizations who said it reaffirmed science-based governance, while Kennedy-aligned groups criticized it as judicial interference. The broader political backdrop is a rising wave of vaccine skepticism and growing polarization around public health—tensions that the lawsuit argues are being amplified, rather than calmed, by abrupt changes to federal recommendations and advisory processes.
Overall, the ruling is a significant check on executive-driven changes to vaccine policy: it signals that even a cabinet secretary cannot rapidly reshape vaccine recommendations and advisory structures without following legal and procedural requirements—and it temporarily preserves the traditional, expert-led framework for U.S. childhood immunization guidance.
